Publicacións nas que colabora con Julio Núñez Villota (32)

2024

  1. Heart failure biomarkers and prediction of early left ventricle remodeling after acute coronary syndromes

    Clinical Biochemistry, Vol. 131-132

  2. Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction

    American Journal of Cardiology, Vol. 211, pp. 9-16

2022

  1. Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

    Journal of Clinical Medicine, Vol. 11, Núm. 11

  2. Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials

    American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575

2021

  1. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772

  2. Direct oral anticoagulants versus warfarin in octogenarians with nonvalvular atrial fibrillation: A systematic review and meta‐analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 22

  3. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  4. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

  5. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  6. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  7. Predictive value of pro-bnp for heart failure readmission after an acute coronary syndrome

    Journal of Clinical Medicine, Vol. 10, Núm. 8

  8. Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  9. Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction

    Journal of Cardiac Failure, Vol. 27, Núm. 4, pp. 427-434

  10. Tratamiento hipolipemiante en los pacientes con enfermedad cardiovascular de riesgo muy elevado. Documento de consenso SEC sobre las indicaciones de los iPCSK9 en la práctica clínica

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

2020

  1. Beneficio del tratamiento invasivo en ancianos con comorbilidades y síndrome coronario agudo sin elevación del ST

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 315-315

  2. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

    American Journal of Medicine, Vol. 133, Núm. 3, pp. 370-380.e4

  3. Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure

    ESC Heart Failure, Vol. 7, Núm. 6, pp. 3320-3328

  4. Estimation of the major cardiovascular events prevention with Inclisiran

    Atherosclerosis, Vol. 313, pp. 76-80

  5. Relevancia de la carga de comorbilidades en el manejo invasivo del síndrome coronario agudo en pacientes ancianos

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 316-316

  6. The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects

    Journal of the American Medical Directors Association, Vol. 21, Núm. 7, pp. 915-918